WC
NUS icon

Wexford Capital’s Nu Skin NUS Stock Holding History

Wexford Capital’s Portfolio NUS Stock Details NUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-3,321
Closed -$40.5K – 484
2025
Q3 		$40.5K Buy
+3,321
New +$34.9K 0.01% 327

Other funds holding NUS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PGCM
Prescott Group Capital Management Tulsa, Oklahoma $1B AUM 51.95% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wexford Capital's NUS Position: Q4 2025 in Review

Wexford Capital sold out of Nu Skin (NUS) in Q4 2025, closing a stake of 3,321 shares — an estimated $40.5K sold.

Wexford Capital first reported a position in NUS in Q3 2025 and held it in 1 quarter. The position peaked at $40.5K in Q3 2025. 187 funds tracked by Wall St. Rank hold NUS as of Q4 2025.

  • Wexford Capital reported no remaining Nu Skin position as of Q4 2025 after selling out during the quarter.
  • Wexford Capital sold 3,321 Nu Skin shares in Q4 2025, an estimated $40.5K.
  • Wexford Capital first reported a position in Nu Skin in Q3 2025 and held it in 1 quarter.
  • Wexford Capital's Nu Skin position peaked at $40.5K in Q3 2025.
  • 187 funds tracked by Wall St. Rank held Nu Skin as of Q4 2025.

Based on Wexford Capital's 13F filing for Q4 2025, filed 13 Feb 2026.